OCREVUS® subcutaneous (SC) injection offers a new 10-minute administration with comparable efficacy and safety to intravenous (IV) infusion Provides an…
The Appointment underscores the company's continued commitment to pioneering future-ready financial management that bridges traditional and crypto finance globally. SINGAPORE, June…
SINGAPORE, June 24, 2024 /PRNewswire/ -- GenScript, the world-leading biotechnology company specializing in life science research and applications, hosted the…